Core Viewpoint - Warren Buffett will not take the main stage at the upcoming shareholder meeting, as confirmed by his daughter Susan, indicating a shift in leadership dynamics at Berkshire Hathaway [1] Group 1: Shareholder Meeting Arrangements - Susan Buffett mentioned that if health permits, Warren Buffett will sit in the front row with other board members and executives during the next shareholder meeting [1] - Greg Abel revealed that the announcement regarding the shareholder meeting's new arrangements was made due to numerous inquiries from suppliers and stakeholders about the future direction of the meeting [1] - The 2026 Berkshire Hathaway shareholder meeting is scheduled for May 2, with a Q&A session planned for that morning, and further details will be released in early next year alongside the annual report [1] Group 2: Emotional Impact - Susan noted that many attendees were emotional during Warren Buffett's last address at the shareholder meeting, highlighting the memorable atmosphere of the event [1]

Core Viewpoint - The article discusses the cyclical nature of the stock market, emphasizing the rotation of styles and the inevitable return to value after periods of overvaluation in certain sectors [2]. Market Trends and Historical Context - In 2012-2013, small-cap stocks and the ChiNext index saw significant gains, while large-cap stocks were undervalued with a P/E ratio below 10 times [2]. - The second half of 2014 witnessed a rapid increase in large-cap stocks led by brokerage firms, while the ChiNext index remained stagnant [2]. - In 2015, the market shifted back to growth stocks, with the ChiNext index experiencing a 150% increase over four months, despite large-cap stocks remaining flat [2][3]. - The market peaked in May 2015, leading to a significant downturn with many stocks hitting their lower limits [3]. - From 2016 to 2018, overvalued growth stocks faced a three-year decline, while large-cap stocks began a small bull market, with leading banks reaching a valuation of 10 times [3]. - The market saw a downturn in 2018, with the ChiNext index suffering substantial losses [3]. - Between 2019 and 2021, strong stocks in sectors like oil and banking faced declines, while growth stocks in consumption, pharmaceuticals, and technology surged, with the ChiNext index rising by 200% [3]. - 2022 was another down year, but by early 2023, value stocks in banking, telecommunications, and oil began to lead the market again, with many doubling in value [3]. Future Outlook - By May 2025, the market shows signs of potential shifts, with banks, telecommunications, and oil stocks having doubled, but some are experiencing declining performance [4]. - Leading companies in consumption and manufacturing have seen their dividend yields drop below 4% or even 5% due to declines or growth [4]. - The pharmaceutical sector, which has faced a four-year decline, is beginning to stabilize, with new consumption trends emerging and significant breakthroughs in drug development [4]. - The market is seeing an influx of new capital, with state-owned enterprises supporting the market, insurance funds investing in high-dividend stocks, and speculative funds driving up small-cap stocks [4].

《经济学人》杂志称他为 " 投资界的卡珊德拉 " （古希腊神话中的人物，她的故事充满 悲剧与象征意 义 ，在现代语境中常被用来形容那些 " 说了真话却没人相信 " 的人） ，虽然他看空市场，但预测往 往精准。 "现在价值股和成长股的估值差距太大了，处于历史的极端水平；而美国和非美市场之间的差距，也差 不多接近历史极值了。 目前格兰桑已经不再管理 GMO 的资金，但他仍然通过 " 格兰桑家族基金会 " 活跃于投资领域，该基 金会专注于应对气候变化，并将大部分资金投入了绿色风险投资企业。 在这场访谈中，杰里米 · 格兰桑再次展现了他一贯的敏锐和坦率。他并不试图用短期的市场情绪来解 释走势，而是将视角拉长，从历史的经验出发，去揭示泡沫的结构、风险的本质、投资者心理的惯性， 以及如何在极端估值和结构性偏差的市场中保持理性。 他指出，当前的市场迷雾重重，传统估值模型全面失灵。疫情后的财政刺激将大量资金送入散户手中， AI 的兴起又制造出一波 " 超级叙事 " ，而地缘政治与关税冲突则增加了政策不可预测性。这三大变量 叠加，让整个系统变得极度难以判断。 所以你该做的是两件事： 多关注价值股，少碰高估成长股，把重心放在美国 ...

Market Performance - The S&P 500 index rose by 0.4% on Thursday, marking four consecutive days of gains, driven by strong performance in value stocks, particularly high-dividend stocks [1][2] - The Nasdaq 100 index only slightly increased by 0.1%, primarily due to declines in major tech stocks, which had previously led the market recovery [1] Sector Performance - Utility, consumer staples, and real estate sectors, characterized by relatively low valuations and stable dividends, led the market gains, with American Water Works, Campbell Soup Company, and Invitation Homes Inc. seeing significant stock price increases [2] - The consumer staples sector surged nearly 3%, real estate rose by 1.8%, and utilities increased by 2.1%, while technology and communication services sectors experienced declines of 0.7% and 0.4%, respectively [9] Economic Indicators - Weak retail sales and producer price data in April reinforced expectations for at least two interest rate cuts by the Federal Reserve this year, leading to a decline in U.S. Treasury yields [5] - Despite solid sales and profit growth, Walmart reported a drop in operating profit and warned of upcoming price increases due to rising tariff costs, resulting in a 0.5% decline in its stock price [5] Corporate Developments - Foot Locker's stock surged by 86% following news of its acquisition by Dick's Sporting Goods for approximately $2.4 billion, marking the largest single-day increase since at least 1980 [10] - Cisco provided a strong quarterly earnings outlook, driven by robust demand for AI network systems infrastructure, leading to a nearly 5% increase in its stock price [13] Trade Relations - Recent trade discussions between the U.S. and China resulted in a significant reduction of tariffs, with the new rates for most goods dropping from 145% to 30% [8] - Despite the positive trade developments, the average tariff rate in the U.S. remains at its highest level since 1934, indicating ongoing trade tensions [8]

Financial Performance - The company reported a total revenue of 1.511 billion yuan for Q1 2025, an increase of 11.29% year-on-year [1] - The net profit attributable to shareholders reached 301 million yuan, reflecting a year-on-year growth of 13.35% [1] - The gross profit margin improved to 74.69%, up by 5.53% compared to the previous year [1] - The net profit margin also increased to 19.9%, a rise of 2.08% year-on-year [1] - The company's operating cash flow per share was 0.31 yuan, marking a significant increase of 35.53% year-on-year [1] Accounts Receivable and Liabilities - Accounts receivable rose significantly, with a year-on-year increase of 50.86%, reaching 1.686 billion yuan [1] - The company reduced its interest-bearing liabilities by 62.21%, bringing them down to 31.721 million yuan [1] Market Position and Analyst Insights - The company's return on invested capital (ROIC) was reported at 16.19%, indicating strong capital returns [3] - Analysts expect the company's revenue for 2025 to be around 1.32 billion yuan, with an average earnings per share forecast of 1.3 yuan [3] - The company has a notable presence among institutional investors, with a prominent fund manager recently increasing their stake [3] Fund Holdings - The largest fund holding the company’s shares is the Huatai-PineBridge Innovation Medicine Mixed Fund, which has a scale of 4.675 billion yuan [4] - The fund manager of this fund has a strong track record, ranking second in the 2024 public fund manager list [4] Strategic Plans - The company plans to accelerate the launch of new drugs and enhance the promotion of existing non-collection products while managing costs effectively [5]

Core Viewpoint - The article emphasizes the importance of understanding the fundamental differences between the Hong Kong stock market and the A-share market, urging investors to remain rational and prepared for risks when participating in the Hong Kong market [1][3][4]. Group 1: Investment Strategies - Investors are increasingly focusing on Hong Kong-listed companies, with a notable presence of Hong Kong heavyweights in A-share fund portfolios, indicating a shift in investment strategies [1]. - The article suggests that early-career fund managers should prioritize studying established companies with proven business models rather than speculative growth stocks, which are harder to predict [2][12]. - The concept of "basic questions" versus "additional questions" in investment is introduced, advocating for a focus on value stocks based on free cash flow as a safer approach for novice fund managers [11][13]. Group 2: Market Dynamics - The article highlights the independent pricing system of the Hong Kong market, which requires investors to understand its unique risks, especially for those accustomed to A-share investment logic [3][4]. - It points out that the Hong Kong market relies heavily on fundamental analysis for pricing, contrasting with the thematic investment approach prevalent in the A-share market [4][6]. - The liquidity disparity between the two markets is significant, with A-share market transaction volumes being approximately ten times higher than those in the Hong Kong market, affecting asset pricing efficiency [4][6]. Group 3: Risk Management - The article warns that the Hong Kong market can present "pits" for uninformed investors, emphasizing the need for thorough market understanding and risk management strategies [3][5]. - It discusses the importance of monitoring capital flows and external market impacts, as the Hong Kong market is sensitive to liquidity changes and foreign investment trends [5][9]. - The article also notes that while institutional investors may appear rational, they can engage in trend-following behaviors that inflate stock valuations, highlighting the need for caution [10][14]. Group 4: Long-term Investment Perspective - The article advocates for a long-term investment approach, emphasizing the need for patience and thorough research in identifying undervalued stocks in the Hong Kong market [6][8]. - It suggests that successful investment requires a deep understanding of a company's fundamentals, management quality, and market positioning, rather than relying solely on market trends [12][13]. - The importance of maintaining a diversified portfolio to manage risks and achieve stable returns in the volatile Hong Kong market is also emphasized [7][8].